# Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib

> **NCT00348491** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 364 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Lumiracoxib

## Key facts

- **NCT ID:** NCT00348491
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-05
- **Final completion:** —
- **Target enrollment:** 364 (—)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348491, "Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00348491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*